Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

Part of paid clinical trials in San Diego, California.

Sponsor
Saol Therapeutics Inc
Study ID
NCT07226258
Phase
PHASE3
Status
Recruiting

Conditions

  • Osteoarthritis Knee Pain

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SL1002 — DRUG
    SL1002 injectable solution
  • Normal Saline — DRUG
    Normal Saline

Study Details

A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.

Key Dates

Start date
Nov 7, 2025
Status verified
May 2026
Primary completion
Nov 30, 2026
Completion
Feb 28, 2027

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT

Arms

  • Experimental: SL1002
    SL1002
  • Placebo Comparator: Placebo
    Normal saline

Primary Outcome Measure

Change From Baseline to Week 12 in the Weekly Mean of the Average Daily Pain Intensity While Walking [ Time Frame: Baseline to week 12 ]

Central Contacts

Locations (20)

FacilityCityStateZIPSite coordinators
Innovative Pain Treatment SolutionsSan DiegoCalifornia92111
Krishnan Chakravarthy, M.D., Ph.D.
770-274-0827
Krishnan Chakravarthy, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR)
DBPS Research, LLCGreenwood VillageColorado80111
Scott Bainbridge, MD
770-274-0827
Scott Bainbridge, M.D. (PRINCIPAL_INVESTIGATOR)
International Spine, Pain & Performance CenterWashington D.C.District of Columbia20006
Mehul Desai, MD
770-274-0827
Mehul Desai, M.D. (PRINCIPAL_INVESTIGATOR)
Prime Medical ResearchCoral GablesFlorida33134
Miguel Telleria, M.D.
770-274-0827
Miguel Telleria, M.D. (PRINCIPAL_INVESTIGATOR)
Conquest Research, LLCOrlandoFlorida32832
Jorge Fernandez-Silva, M.D.
770-274-0827
Jorge Fernandez-Silva, M.D. (PRINCIPAL_INVESTIGATOR)
Conquest Research, LLCWinter ParkFlorida32789
Anand Patel, M.D.
770-274-0827
Anand Patel, M.D. (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55905
Ryan D"Souza, M.D.
770-274-0827
Ryan D'Souza, M.D. (PRINCIPAL_INVESTIGATOR)
Queen City Clinical Research, PLLCCharlotteNorth Carolina28211
Christopher Gilmore, M.D.
770-274-0827
Christopher Gilmore, M.D. (PRINCIPAL_INVESTIGATOR)
The Center for Clinical ResearchWinston-SalemNorth Carolina27103
Leonardo Kapural, MD
770-274-0827
Leonardo Kapural, M.D. (PRINCIPAL_INVESTIGATOR)
Comprehensive Specialty CareEdmondOklahoma73034
Douglas Beall, M.D.
770-274-0827
Douglas Beall, M.D. (PRINCIPAL_INVESTIGATOR)
Pacific Sports and SpineEugeneOregon97404
Gregory Moore, M.D.
770-274-0827
Gregory Moore, M.D. (PRINCIPAL_INVESTIGATOR)
University Orthopedics CenterAltoonaPennsylvania16602
Fred Khalouf, D.O.
770-274-0827
Fred Khalouf, D.O. (PRINCIPAL_INVESTIGATOR)
Pain Diagnostics & Interventional Care LLCSewickleyPennsylvania15143
David Provenzano, M.D.
770-274-0827
David Provenzano, M.D. (PRINCIPAL_INVESTIGATOR)
Medical University of South Carolina (MUSC)CharlestonSouth Carolina29425
Ameet Nagpal, M.D.
770-274-0827
Ameet Nagpal, M.D. (PRINCIPAL_INVESTIGATOR)
PCPMG Clinical Research Unit, LLCGreenvilleSouth Carolina29601
Brian Jakubowicz, M.D.
770-274-0827
Brian Jakubowicz, M.D. (PRINCIPAL_INVESTIGATOR)
Legent Orthopedic and Spine HospitalBellaireTexas77401
Daneshvari Solanki, MD
770-274-0827
Daneshvari Solanki, M.D. (PRINCIPAL_INVESTIGATOR)
Institute of Precision Pain MedicineCorpus ChristiTexas78414
Mitchell Engle, M.D.
770-274-0827
Mitchell Engle, M.D. (PRINCIPAL_INVESTIGATOR)
International Spine, Pain & Performance Center (IPP)TylerTexas75701
Aaron Calodney, M.D.
770-274-0827
Aaron Calodney, M.D. (PRINCIPAL_INVESTIGATOR)
University of Utah Orthopedic CenterSalt Lake CityUtah84108
Zachary McCormick, M.D.
770-274-0827
Zachary McCormick, M.D. (PRINCIPAL_INVESTIGATOR)
Virginia iSpine Physicians, PCRichmondVirginia23238
Michael DePalma, MD
770-274-0827
Michael DePalma, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Diego, CA